CoTIL-01 / Instil Bio - LARVOL DELTA

OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial) (clinicaltrials.gov) - P1/2; N=0; Withdrawn; Sponsor: Immetacyte Ltd; N=22 ➔ 0; Not yet recruiting ➔ Withdrawn

Clinical • Enrollment change • Trial withdrawal • Complement-mediated Rare Disorders • Oncology • Ovarian Cancer • Ovarian Serous Adenocarcinoma • Solid Tumor • IL2

OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial) (clinicaltrials.gov) - P1/2; N=22; Not yet recruiting; Sponsor: Immetacyte Ltd

Clinical • New P1/2 trial • Complement-mediated Rare Disorders • Gynecologic Cancers • Oncology • Ovarian Cancer • Ovarian Serous Adenocarcinoma • Primary Immunodeficiency